Chris Carr - Sweetgreen Chief Officer
| SG Stock | USD 39.23 1.75 4.27% |
Insider
Chris Carr is Chief Officer of Sweetgreen
| Age | 60 |
| Address | 3102 36th Street, Los Angeles, CA, United States, 90018 |
| Phone | 323 990 7040 |
| Web | https://www.sweetgreen.com |
Sweetgreen Management Efficiency
The company has Return on Asset (ROA) of (0.0648) % which means that for every 100 dollars spent on asset, it generated a loss of $0.0648. This is way below average. Likewise, it shows a return on total equity (ROE) of (0.1842) %, which implies that it produced no returns to current stockholders. Sweetgreen's management efficiency ratios could be used to measure how well Sweetgreen manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.16. The current Return On Capital Employed is estimated to decrease to -0.18. At this time, Sweetgreen's Net Tangible Assets are most likely to increase significantly in the upcoming years. The Sweetgreen's current Debt To Assets is estimated to increase to 0.07, while Non Currrent Assets Other are projected to decrease to roughly 57.1 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Lisa LeCointeCephas | Merck Company | 42 | |
| W Keenan | Antero Midstream Partners | 69 | |
| Alan Russell | Edgewise Therapeutics | 54 | |
| Michael Klobuchar | Merck Company | 45 | |
| Brendan Krueger | Antero Midstream Partners | 39 | |
| Al Williams | Chevron Corp | N/A | |
| Jennifer Mauer | Merck Company | N/A | |
| Michael Fleming | Merck Company | 61 | |
| Russell MS | Acumen Pharmaceuticals | 66 | |
| Stephen Mayo | Merck Company | 59 | |
| Michael Bauer | QCR Holdings | 75 | |
| Liean MS | Acumen Pharmaceuticals | N/A | |
| Julie Bockenstette | Acumen Pharmaceuticals | N/A | |
| Jannie Oosthuizen | Merck Company | 53 | |
| Arpa Garay | Merck Company | 42 | |
| Dean Li | Merck Company | 58 | |
| Patrick Ash | Antero Midstream Partners | 45 | |
| Paul Antebi | Chevron Corp | 47 | |
| David Williams | Merck Company | 55 | |
| Ringo Tsang | Highway Holdings Limited | 58 | |
| Behrad Derakhshan | Edgewise Therapeutics | 44 | |
Management Performance
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0648 |
Sweetgreen Leadership Team
Elected by the shareholders, the Sweetgreen's board of directors comprises two types of representatives: Sweetgreen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sweetgreen. The board's role is to monitor Sweetgreen's management team and ensure that shareholders' interests are well served. Sweetgreen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sweetgreen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rossann Williams, Chief Officer | ||
| Chad Brauze, Head Culinary | ||
| Rebecca Nounou, Head Relations | ||
| Daniel Shlossman, Chief Officer | ||
| Christopher Tarrant, Senior Officer | ||
| Michael Kotick, VP Marketing | ||
| Jonathan Neman, Chairman, CoFounder | ||
| Nathaniel Ru, Treasurer, CoFounder | ||
| Jim McPhail, Chief Officer | ||
| Wouleta Ayele, Chief Officer | ||
| Adrienne Gemperle, Chief Officer | ||
| Jen D, Director of Customer Experience | ||
| Nicolas Jammet, Secretary, CoFounder | ||
| Timothy Noonan, Senior Development | ||
| Mitch Reback, Chief Officer | ||
| Chris Carr, Chief Officer |
Sweetgreen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sweetgreen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.18 | ||||
| Return On Asset | -0.0648 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.12) % | ||||
| Current Valuation | 4.82 B | ||||
| Shares Outstanding | 103.41 M | ||||
| Shares Owned By Insiders | 2.67 % | ||||
| Shares Owned By Institutions | 97.33 % | ||||
| Number Of Shares Shorted | 13.6 M | ||||
| Price To Earning | 250.00 X |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sweetgreen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. For more detail on how to invest in Sweetgreen Stock please use our How to Invest in Sweetgreen guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Hotels, Restaurants & Leisure space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sweetgreen. If investors know Sweetgreen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sweetgreen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.78) | Revenue Per Share 5.896 | Quarterly Revenue Growth 0.13 | Return On Assets (0.06) | Return On Equity (0.18) |
The market value of Sweetgreen is measured differently than its book value, which is the value of Sweetgreen that is recorded on the company's balance sheet. Investors also form their own opinion of Sweetgreen's value that differs from its market value or its book value, called intrinsic value, which is Sweetgreen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sweetgreen's market value can be influenced by many factors that don't directly affect Sweetgreen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sweetgreen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sweetgreen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sweetgreen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.